INCY · Incyte Corp · Insider Trading

$121.47 -1.81 (-1.47%) At close · Sep 11

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$24.63B

199.78M

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.

Query insider transactions through the insider trading API or MCP →

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2026-08-25	Basi Ramitpal K	EVP, Human Resources	Tax↓ Filing footnotes — Common Stock (Direct) Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock. This includes an aggregate of 9,871 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.	Common Stock	504	$129.72	$65,379	10,993
2026-08-19	CAGNONI PABLO J	President, R&D	Sell↓ Filing footnotes — Common Stock (Direct) This includes an aggregate of 183,200 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.	Common Stock	10,801	$125.56	$1,356,174	183,200
2026-08-12	CAGNONI PABLO J	President, R&D	Sell↓ Filing footnotes — Common Stock (Direct) This includes an aggregate of 183,200 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.	Common Stock	10,803	$120.04	$1,296,792	194,001
2026-08-05	CAGNONI PABLO J	President, R&D	Sell↓ Filing footnotes — Common Stock (Direct) This includes an aggregate of 183,200 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.	Common Stock	10,640	$122.69	$1,305,422	204,804
2026-08-05	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↑	Common Stock	2,207	$106.47	$234,979	63,648
2026-08-05	Mayes Patrick A	EVP & Chief Scientific Officer	Sell↓ Filing footnotes — Common Stock (Direct) This includes an aggregate of 59,537 shares of common stock issuable pursuant to previously reported restricted stock units have not vested.	Common Stock	2,207	$123.99	$273,646	61,441
2026-08-05	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↓ Filing footnotes — Employee Stock Option (right to buy) (Direct) As of August 5th, 2026, the award is fully vested and exercisable	Employee Stock Option (right to buy)	2,207	—	—	0
2026-08-03	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↓ Filing footnotes — Employee Stock Option (right to buy) (Direct) As of July 31st, 2026, the award is fully vested and exercisable.	Employee Stock Option (right to buy)	6,055	—	—	0
2026-08-03	Mayes Patrick A	EVP & Chief Scientific Officer	Sell↓ Filing footnotes — Common Stock (Direct) This includes an aggregate of 59,537 shares of common stock issuable pursuant to previously reported restricted stock units have not vested.	Common Stock	6,055	$120.43	$729,204	61,441
2026-08-03	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↑	Common Stock	6,055	$105.43	$638,379	67,496
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↓ Filing footnotes — Employee Stock Option (right to buy) (Direct) As of July 31st, 2026, the award is fully vested and exercisable.	Employee Stock Option (right to buy)	2,623	—	—	0
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Sell↓	Common Stock	4,695	$119.39	$560,536	70,294
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↓ Filing footnotes — Employee Stock Option (right to buy) (Direct) Options granted on January 18, 2024 and will vest monthly through July 14, 2027	Employee Stock Option (right to buy)	2,918	—	—	1,328
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↑	Common Stock	1,642	$85.01	$139,586	100,636
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Sell↓	Common Stock	2,187	$119.47	$261,281	81,160
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↓ Filing footnotes — Employee Stock Option (right to buy) (Direct) As of July 31st, 2026, the award is fully vested and exercisable.	Employee Stock Option (right to buy)	85	—	—	2,207
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↑	Common Stock	2,864	$77.67	$222,447	91,705
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Sell↓	Common Stock	326	$121.69	$39,671	63,734
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↑	Common Stock	326	$105.43	$34,370	103,340
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Sell↓	Common Stock	2,864	$119.40	$341,962	67,430
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↓ Filing footnotes — Employee Stock Option (right to buy) (Direct) As of July 31st, 2026, the award is fully vested and exercisable.	Employee Stock Option (right to buy)	2,864	—	—	191
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Sell↓	Common Stock	85	$122.19	$10,386	64,060
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↑	Common Stock	2,709	$61.76	$167,308	71,539
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Sell↓	Common Stock	2,293	$119.41	$273,807	61,441
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↓ Filing footnotes — Employee Stock Option (right to buy) (Direct) Options granted on January 17, 2025 and will vest monthly through July 15, 2028	Employee Stock Option (right to buy)	2,072	—	—	2,665
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↑	Common Stock	2,293	$90.56	$207,654	102,929
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↓ Filing footnotes — Employee Stock Option (right to buy) (Direct) Options granted on July 15, 2024 and will vest monthly through July 15, 2028	Employee Stock Option (right to buy)	2,284	—	—	2,938
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↑	Common Stock	2,284	$64.25	$146,747	68,830
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↑	Common Stock	2,623	$83.58	$219,230	98,994
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↓ Filing footnotes — Employee Stock Option (right to buy) (Direct) As of July 31st, 2026, the award is fully vested and exercisable.	Employee Stock Option (right to buy)	3,023	—	—	202
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Sell↓	Common Stock	14,661	$119.46	$1,751,403	88,679
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↓ Filing footnotes — Employee Stock Option (right to buy) (Direct) As of July 31st, 2026, the award is fully vested and exercisable.	Employee Stock Option (right to buy)	3,148	—	—	0
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↑	Common Stock	2,072	$71.93	$149,039	76,759
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↑	Common Stock	3,023	$83.20	$251,514	96,371
2026-07-31	CAGNONI PABLO J	President, R&D	Sell↓ Filing footnotes — Common Stock (Direct) This includes an aggregate of 183,200 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.	Common Stock	15,888	$119.70	$1,901,794	215,444
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↑	Common Stock	1,643	$80.50	$132,262	93,348
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↓ Filing footnotes — Employee Stock Option (right to buy) (Direct) As of July 31st, 2026, the award is fully vested and exercisable.	Employee Stock Option (right to buy)	2,623	—	—	0
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Sell↓	Common Stock	1,642	$119.38	$196,022	64,145
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↓ Filing footnotes — Employee Stock Option (right to buy) (Direct) As of July 31st, 2026, the award is fully vested and exercisable.	Employee Stock Option (right to buy)	9,459	—	—	0
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↓ Filing footnotes — Employee Stock Option (right to buy) (Direct) As of July 31st, 2026, the award is fully vested and exercisable.	Employee Stock Option (right to buy)	1,643	—	—	0
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↑	Common Stock	3,148	$68.62	$216,016	74,687
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↓ Filing footnotes — Employee Stock Option (right to buy) (Direct) As of July 31st, 2026, the award is fully vested and exercisable.	Employee Stock Option (right to buy)	1,642	—	—	0
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↓ Filing footnotes — Employee Stock Option (right to buy) (Direct) As of July 31st, 2026, the award is fully vested and exercisable.	Employee Stock Option (right to buy)	326	—	—	6,055
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↓ Filing footnotes — Employee Stock Option (right to buy) (Direct) As of July 31st, 2026, the award is fully vested and exercisable.	Employee Stock Option (right to buy)	2,293	—	—	0
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↑	Common Stock	85	$106.47	$9,050	103,014
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↓ Filing footnotes — Employee Stock Option (right to buy) (Direct) Options granted on July 14, 2023 and will vest monthly through July 14, 2027	Employee Stock Option (right to buy)	2,709	—	—	1,233
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↑	Common Stock	2,623	$74.78	$196,148	88,841
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Sell↓	Common Stock	6,171	$119.43	$737,003	74,989
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Convert↑	Common Stock	2,918	$61.18	$178,523	66,546
2026-07-31	Mayes Patrick A	EVP & Chief Scientific Officer	Sell↓	Common Stock	5,332	$119.42	$636,747	83,347

Legend Buy — open-market purchase Sell — open-market sale ↑ Shares acquired ↓ Shares disposed (gift, conversion, tax…)

Showing 1–50 of 1,311 transactions

Key facts CIK 879169 CUSIP 45337C102 13F (30d) 283 filings 278 filers Visit website Investor relations